Journal of Global Infectious DiseasesOfficial Publishing of INDUSEM and OPUS 12 Foundation, Inc. Users online:894  
Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size     
Home About us Editors Ahead of Print Current Issue Archives Search Instructions Subscribe Advertise Login 
 
This article has been cited by
1The reliability of rifampicin resistance as a proxy for multidrug-resistant tuberculosis: a systematic review of studies from Iran
M. J. Nasiri,S. Zamani,A. Pormohammad,M. M. Feizabadi,H. R. Aslani,M. Amin,R. Halabian,A. A. Imani Fooladi
European Journal of Clinical Microbiology & Infectious Diseases.2018;37(1)9
[DOI]
2A review of the use of ethionamide and prothionamide in childhood tuberculosis
S. Thee,A.J. Garcia-Prats,P.R. Donald,A.C. Hesseling,H.S. Schaaf
Tuberculosis.2016;97(1)126
[DOI]
3The 7H11 Agar Medium Supplemented with Calf Bovine Serum for Susceptibility Testing of Mycobacterium tuberculosis Isolates Against Pyrazinamide
Sirus Amini,Jalil Kardan-Yamchi,Hossein Kazemian,Mohammad Javad Nasiri,Gholamreza Hamzehloo,Sven Hoffner,Mohammad Mehdi Feizabadi
Microbial Drug Resistance.2021;97(1)126
[DOI]
4Evaluation of GeneXpert MTB/RIF for determination of rifampicin resistance among new tuberculosis cases in west and northwest Iran
S. Atashi,B. Izadi,S. Jalilian,S.H. Madani,A. Farahani,P. Mohajeri
New Microbes and New Infections.2017;19(1)117
[DOI]
5Isoniazid-resistant tuberculosis in Iran: A systematic review
Mohammad Javad Nasiri,Alireza Salimi Chirani,Mohsen Amin,Raheleh Halabian,Abbas Ali Imani Fooladi
Tuberculosis.2016;98(1)104
[DOI]
6Prevalence of tuberculosis and multidrug resistant tuberculosis in the Middle East Region
Suhail Ahmad,Eiman Mokaddas,Noura M. Al-Mutairi
Expert Review of Anti-infective Therapy.2018;16(9)709
[DOI]
7Cyclic di-GMP regulates Mycobacterium tuberculosis resistance to ethionamide
Hai-Nan Zhang,Zhao-Wei Xu,He-Wei Jiang,Fan-Lin Wu,Xiang He,Yin Liu,Shu-Juan Guo,Yang Li,Li-Jun Bi,Jiao-Yu Deng,Xian-En Zhang,Sheng-Ce Tao
Scientific Reports.2017;7(1)709
[DOI]
8The frequency of point mutations associated with resistance to isoniazid and rifampin among clinical isolates of multidrug-resistant Mycobacterium tuberculosis in the west of Iran
Zahra Hamed,Parviz Mohajeri,Abbas Farahani,Jebreil Shamseddin,Masoud Zandi,Babak Izadi,Sara Atashi,Mahsa Dastranj
Gene Reports.2021;22(1)100981
[DOI]
9Synergistic interactions of ionic liquids and antimicrobials improve drug efficacy
Daniel D. Yang,Nicholas J. Paterna,Alexandria S. Senetra,Kaitlyn R. Casey,Phillip D. Trieu,Gregory A. Caputo,Timothy D. Vaden,Benjamin R. Carone
iScience.2021;24(1)101853
[DOI]
10First-Line Anti-Tubercular Drug Resistance of Mycobacterium tuberculosis in IRAN: A Systematic Review
Babak Pourakbari,Setareh Mamishi,Mona Mohammadzadeh,Shima Mahmoudi
Frontiers in Microbiology.2016;7(1)101853
[DOI]
11Patientsí Experience of Tuberculosis Treatment Using Directly Observed Treatment, Short-Course (DOTS): A Qualitative Study
Masoud Behzadifar,Masoud Mirzaei,Meysam Behzadifar,Abouzar Keshavarzi,Maryam Behzadifar,Maryam Saran
Iranian Red Crescent Medical Journal.2015;17(4)101853
[DOI]
  Addresses 
  My Preferences 


JGID
What's new
Forthcoming Symposia
Submit articles
Email alerts
Join us
Most popular articles
Recommend this journal
Sitemap | What's New | Feedback | Copyright and Disclaimer | Contact Us
© 2008 Journal of Global Infectious Diseases | Published by Wolters Kluwer - Medknow
Online since 10th December, 2008